EyePoint Announces First Patient Dosed in Second Global Phase 3 Lucia Clinical Trial of Duravyu™ for the Treatment of Wet Age-Related Macular Degeneration
EyePoint宣佈第二個全球階段3 Lucia臨床試驗首位患者接受Duravyu™治療溼性老年性黃斑變性。
EyePoint Announces First Patient Dosed in Second Global Phase 3 Lucia Clinical Trial of Duravyu™ for the Treatment of Wet Age-Related Macular Degeneration
EyePoint宣佈第二個全球階段3 Lucia臨床試驗首位患者接受Duravyu™治療溼性老年性黃斑變性。
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因